Atlas Trials

Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis

Clinical trial NCT02461069 · COMPLETED

Trial details

NCT number
NCT02461069
Sponsor
University Hospital Muenster
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Multiple Sclerosis, Relapsing-Remitting
Start date
2015-05-06
Primary completion
2018-01-24
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.